Inventor · disambiguated record
Brett T. Staahl
Also filed as: STAAHL BRETT T
8 granted patents·17 pending applications·58 citations·filing 2015–2024
87Inventor score
Top patents by PatentIndex Score
25 records- 0194US11560555B2Engineered proteinsSCRIBE THERAPEUTICS INC·Filed 2021·Granted Jan 24, 2023·15 cites·25 claims
- 0294US10570418B2Methods and compositions for RNA-directed target DNA modificationUNIV CALIFORNIA·Filed 2015·Granted Feb 25, 2020·12 cites·10 claims
- 0393US12084692B2Guide scaffoldsSCRIBE THERAPEUTICS INC·Filed 2022·Granted Sep 10, 2024·5 cites·38 claims
- 0493US11535835B1Compositions and methods for the targeting of rhodopsinSCRIBE THERAPEUTICS INC·Filed 2021·Granted Dec 27, 2022·7 cites·26 claims
- 0592US11613742B2Compositions and methods for the targeting of SOD1SCRIBE THERAPEUTICS INC·Filed 2021·Granted Mar 28, 2023·4 cites·25 claims
- 0691US12163125B2Engineered class 2 type V CRISPR systemsSCRIBE THERAPEUTICS INC·Filed 2022·Granted Dec 10, 2024·5 cites·28 claims
- 0788US11976277B2Particle delivery systemsSCRIBE THERAPEUTICS INC·Filed 2023·Granted May 7, 2024·3 cites·23 claims
- 0888US11118194B2Modified site-directed modifying polypeptides and methods of use thereofUNIV CALIFORNIA·Filed 2016·Granted Sep 14, 2021·7 cites·13 claims
- 0985US2025136962A1Catalytically dead engineered proteinsSCRIBE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1084US2025043262A1Gene editing pairsSCRIBE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1180US2025011756A1Methods of editing with engineered class 2 type v crispr systemsSCRIBE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1274US2024101984A1Compositions and methods for the targeting of sod1SCRIBE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1374US2022220508A1Engineered casx systemsSCRIBE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1470US2024026385A1Engineered class 2 type v crispr systemsSCRIBE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1564US2024360474A1Self-inactivating vectors for gene editingSCRIBE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1663US2022348925A1Compositions and methods for the targeting of sod1SCRIBE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1761US2025361525A1Aav vectors for gene editingSCRIBE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1860US2024309344A1COMPOSITIONS AND METHODS FOR THE TARGETING OF C9orf72SCRIBE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1960US2023033866A1Compositions and methods for the targeting of rhodopsinSCRIBE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2059US2023032369A1Compositions and methods for the targeting of httSCRIBE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2157US2024026386A1Compositions and methods for the targeting of bcl11aSCRIBE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2255US2024100185A1Compositions and methods for the targeting of ptbp1SCRIBE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2353US2023167424A1Compositions and methods for the targeting of pcsk9SCRIBE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2452US2024033377A1Aav vectors for gene editingSCRIBE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2544US2020115688A1Compositions and methods for enhancing genome editingUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brett T. Staahl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →